Centene Corporation, listed under the ticker CNC, operates in the healthcare sector, providing essential services to the under-insured and uninsured population in the U.S. Recent analyses indicate stable growth potential due to its diversified offerings. However, the heavily regulated nature of its business may present challenges.
The stock's fundamental rating suggests a strong performance across several key financial metrics, indicating robust company health and promising growth potential.
Category | Score | Visual |
---|---|---|
Discounted Cash Flow | 5 | |
Return on Equity | 4 | |
Return on Assets | 4 | |
Debt to Equity | 1 | |
Price to Earnings | 3 | |
Price to Book | 4 |
Examining historical data provides insight into the company's consistent performance over time.
Date | Overall Score | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
---|---|---|---|---|---|---|---|
2025-07-11 | 4 | 5 | 4 | 4 | 1 | 3 | 4 |
--- | 0 | 5 | 4 | 4 | 1 | 3 | 4 |
Analysts have set varied price targets, reflecting differing perspectives on future performance, yet consensus leans towards potential price growth.
High | Low | Median | Consensus |
---|---|---|---|
69 | 45 | 57 | 57 |
Based on current analyst sentiment, the stock is predominantly considered a solid buy option with minimal inclination towards selling.
Rating | Amount | Visual |
---|---|---|
Strong Buy | 0 | |
Buy | 28 | |
Hold | 15 | |
Sell | 0 | |
Strong Sell | 0 |
Centene Corporation's stock shows potential for growth, supported by strong fundamental ratings and positive analyst sentiment. However, investors should be aware of regulatory risks that could affect its healthcare services. The consistent historical performance underscores stability, making CNC a potentially attractive investment for conservative portfolios seeking exposure in the healthcare sector.